Cardiac Disorders in the WHO’s Databaseby Craig Paardekooper

Vigiaccess is the public interface of the WHO’s adverse events monitoring system, where you canenter a pharmaceutical, and it will output the summary statistics of adverse events and demographics
for that product. Vigiaccess can be viewed at http://www.vigiaccess.org
Vigiaccess is simply the public front end for Vigibase, which is the entire WHO database. Vigiaccess islimited because it does not allow bespoke searches, whilst Vigibase does allow bespoke searches, butaccess to Vigibase is restricted to medical and academic personnel and requires a subscription.
As of the 21st August 2022, Vigiaccess has 4,100,000 records of adverse events following vaccination
with COVID-19 gene therapy jabs.

Here is a screenshot of the adverse reactions as of 21st August 2022 –Cardiac Disorders
We are particularly interested in cardiac disorders – which amount to 3% of all recorded adverseevents. These are serious disorders, since they arise from damage to the heart muscle after receiving
the COVID jab.
As of 21st August 2022, Vigiaccess has recorded 265927 cases of cardiac damage following the COVID19 jab.

You can see that ALL of these are very serious. This isn’t like a transient headache or a sore arm. These are all serious
disturbances of the heart brought about by damage and destruction of the heart muscle, and the people who sufferfrom these disorders have reduced capacity for physical exertion, extreme fatigue, are often in constant pain andoften rendered unemployable or even disabled.
So those who take the COVID jab in order to keep their jobs, may actually be doing the exact opposite – ensuringthat they are rendered permanently ill with heart damage – and hence unemployable. Such has been the fate formany pilots, the fate for many soldiers and the fate for many sports people who willingly took the jab to keep theirjobs. If you want some examples you can find them here –Airforce : Army flight surgeon says pilots risk 'sudden cardiac death' from COVID vaccine side effect | American Military News
Military : https://www.howbad.info/military1.pdf
Sports : athletes.pdf (howbad.info)

Vigibase
Vigiaccess doesn’t allow us to go any deeper than this, so to gain further information about cardiac disorders wemust look to those who have accessed Vigibase.
Here is the study – Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19
vaccines - PubMed (nih.gov)
And here are their results -The researchers found that •••a full 4.9% of reports (242 out of 4942 reports) for 12-17 year-olds were myocarditis or pericarditis.
the incidence of myocarditis after the second dose was 5 times that after the first dose .
95% of the myocarditis/pericarditis cases were rated as serious and 79% required hospitalization

Young vs Old
So there is a higher incidence of myocarditis and pericarditis in adolescents (4.9% of reports) than the incidence for
all age groups combined (3% of reports) – indicating that there is a strong skew towards younger age groups in theVigibase database.
First vs Second Dose
Fact checkers would have us to believe that the incidence of myocarditis is no greater than the background rate - orthe rate due to COVID virus.
Even if we ASSUME that the myocarditis after the first dose was just the background rate or the rate due to COVID,
then why does this “background rate” jump up by 5 x after the second dose?
We are forced to conclude that at least 80% of the myocarditis is indeed caused by the vaccine , in 12 to 17 year-olds- that’s a lot of suffering for the very young.
Severity
The other surprising finding of this study was the degree of seriousness of these myocarditis events. 95% were rated
as serious and 79% required hospitalization.
Conclusions
Vigibase confirms the findings from VAERS that young people are more at risk from myocarditis and pericarditis
compared to older age groups, and also confirms the findings from VAERS that second dose confers far greater riskof myocarditis and pericarditis (5 x the risk) compared to the first.
Vigibase also confirms that these cardiac issues are NOT MILD, but are serious adverse events, 4 out of 5 leading tohospitalization.
Getting Access to Vigibase
It is important for researchers, statisticians and doctors to look at ways of obtaining access to Vigibase, so they can
perform searches on a par with VAERS. Therefore, one of the reasons for this article is to ask researchers in this field
if we can come together in an official capacity to obtain authorization for access. See - VigiBase Extract Case Level |UMC (who-umc.org)